C A de Swart - JoVE Visualize

Showing results (1-10 of 8) with videos related to

Pageof 1

Sort By:

Blood|December 1, 1982

Kinetics of intravenously administered heparin in normal humansC A de Swart, B Nijmeyer, J M Roelofs, et al.

Thrombosis and Haemostasis|August 31, 1984

Elimination of intravenously administered radiolabelled antithrombin III and heparin in humansC A de Swart, B Nijmeyer, L O Andersson, et al.

Blood|April 1, 1984

Elimination of high affinity heparin fractions and their anticoagulant and lipase activityC A de Swart, B Nijmeyer, L O Andersson, et al.

Breast Cancer Research and Treatment|June 14, 2000

Randomized phase II study of FEC day 1 + 8 and FEC day 1 in patients with advanced breast cancerD W van Toorn, J W Nortier, M Rubach, et al.

Thrombosis and Haemostasis|October 31, 1983

Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinaseW Theiss, F Asbeck, A Kriessmann, et al.

Thrombosis and Haemostasis|October 31, 1983

Controlled multicenter pilot study of urokinase- heparin and streptokinase in deep vein thrombosisJ C van de Loo, A Kriessmann, G Trübestein, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancerJ P Neijt, S A Engelholm, M K Tuxen, et al.

Medical Oncology (Northwood, London, England)|November 20, 1998

Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapyW W ten Bokkel Huinink, C A de Swart, D W van Toorn, et al.

Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:

Pageof 1

Blood|December 1, 1982

Kinetics of intravenously administered heparin in normal humansC A de Swart, B Nijmeyer, J M Roelofs, et al.

Thrombosis and Haemostasis|August 31, 1984

Elimination of intravenously administered radiolabelled antithrombin III and heparin in humansC A de Swart, B Nijmeyer, L O Andersson, et al.

Blood|April 1, 1984

Elimination of high affinity heparin fractions and their anticoagulant and lipase activityC A de Swart, B Nijmeyer, L O Andersson, et al.

Breast Cancer Research and Treatment|June 14, 2000

Randomized phase II study of FEC day 1 + 8 and FEC day 1 in patients with advanced breast cancerD W van Toorn, J W Nortier, M Rubach, et al.

Thrombosis and Haemostasis|October 31, 1983

Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinaseW Theiss, F Asbeck, A Kriessmann, et al.

Thrombosis and Haemostasis|October 31, 1983

Controlled multicenter pilot study of urokinase- heparin and streptokinase in deep vein thrombosisJ C van de Loo, A Kriessmann, G Trübestein, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancerJ P Neijt, S A Engelholm, M K Tuxen, et al.

Medical Oncology (Northwood, London, England)|November 20, 1998

Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapyW W ten Bokkel Huinink, C A de Swart, D W van Toorn, et al.

Pageof 1